The co-administration of neutralizing anti-CD8 antibodies severely reduced T-PNU anti-tumor protection and overall survival (Fig. 5a,b) suggesting that T-PNU activates an anti-tumor immunity an suppresses tumor growth through the recruitment of CD8 positive T cells at tumor site which are actively involved in tumor clearing. The gene discussed is CD8A; the disease is neoplasm.